• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚性双环[3.1.0]己烷支架限制组胺的构象,提供选择性 H 受体配体。

Conformational Restriction of Histamine with a Rigid Bicyclo[3.1.0]hexane Scaffold Provided Selective H Receptor Ligands.

机构信息

Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka 422-8526, Japan.

出版信息

Molecules. 2020 Aug 5;25(16):3562. doi: 10.3390/molecules25163562.

DOI:10.3390/molecules25163562
PMID:32764432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463632/
Abstract

We designed and synthesized conformationally rigid histamine analogues with a bicyclo[3.1.0]hexane scaffold. All the compounds were selectively bound to the H receptor subtype over the H receptor subtype. Notably, compound showed potent binding affinity and over 100-fold selectivity for the H receptors ( = 5.6 nM for H and 602 nM for H). These results suggest that the conformationally rigid bicyclo[3.1.0]hexane structure can be a useful scaffold for developing potent ligands selective for the target biomolecules.

摘要

我们设计并合成了具有双环[3.1.0]己烷骨架的刚性组氨酸类似物。所有化合物均选择性地与 H 受体亚型结合,而不是 H 受体亚型。值得注意的是,化合物对 H 受体具有很强的结合亲和力和超过 100 倍的选择性(H 受体的 = 5.6 nM,H 受体的 = 602 nM)。这些结果表明,构象刚性的双环[3.1.0]己烷结构可以作为开发针对靶标生物分子的有效配体的有用支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/753157a9013a/molecules-25-03562-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/f0a75bba683c/molecules-25-03562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/a4d4ba486ed2/molecules-25-03562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/d57652182ede/molecules-25-03562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/a466f7dfb088/molecules-25-03562-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/fc59eb4cda20/molecules-25-03562-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/3cba2a3f9f1a/molecules-25-03562-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/3cdbefcb2679/molecules-25-03562-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/753157a9013a/molecules-25-03562-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/f0a75bba683c/molecules-25-03562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/a4d4ba486ed2/molecules-25-03562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/d57652182ede/molecules-25-03562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/a466f7dfb088/molecules-25-03562-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/fc59eb4cda20/molecules-25-03562-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/3cba2a3f9f1a/molecules-25-03562-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/3cdbefcb2679/molecules-25-03562-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae5/7463632/753157a9013a/molecules-25-03562-g006.jpg

相似文献

1
Conformational Restriction of Histamine with a Rigid Bicyclo[3.1.0]hexane Scaffold Provided Selective H Receptor Ligands.刚性双环[3.1.0]己烷支架限制组胺的构象,提供选择性 H 受体配体。
Molecules. 2020 Aug 5;25(16):3562. doi: 10.3390/molecules25163562.
2
Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.面向立体化学多样性的构象限制策略。具有咪唑基环丙烷结构的强效组胺H3和/或H4受体拮抗剂的研发。
J Med Chem. 2006 Sep 7;49(18):5587-96. doi: 10.1021/jm0603318.
3
Design and synthesis of histamine H/H receptor ligands with a cyclopropane scaffold.具有环丙烷骨架的组胺H/H受体配体的设计与合成。
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3630-3633. doi: 10.1016/j.bmcl.2018.10.041. Epub 2018 Oct 26.
4
Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.基于环丙烷的立体化学多样性导向构象限制策略:具有 2,3-甲烷丁烷骨架的组胺 H3 和/或 H4 受体配体。
Org Biomol Chem. 2012 Jan 28;10(4):736-45. doi: 10.1039/c1ob06496g. Epub 2011 Nov 28.
5
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.基于环丙烷的组胺构象限制。(1S,2S)-2-(2-氨基乙基)-1-(1H-咪唑-4-基)环丙烷,一种组胺H3受体的高选择性激动剂,具有顺式环丙烷结构。
J Med Chem. 2003 May 8;46(10):1980-8. doi: 10.1021/jm020415q.
6
Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.基于结构的 A(3) 腺苷受体选择性核苷设计:2-芳基乙炔基和双环[3.1.0]己烷取代基的组合。
J Med Chem. 2012 May 24;55(10):4847-60. doi: 10.1021/jm300396n. Epub 2012 May 16.
7
Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.构象受限组胺H(3)受体激动剂的合成及构效关系
J Med Chem. 2003 Dec 4;46(25):5445-57. doi: 10.1021/jm030905y.
8
Stereoselective syntheses of highly functionalized bicyclo[3.1.0]hexanes: a general methodology for the synthesis of potent and selective mGluR2/3 agonists.高官能化双环[3.1.0]己烷的立体选择性合成:一种合成强效和选择性代谢型谷氨酸受体2/3激动剂的通用方法。
J Org Chem. 2005 Sep 30;70(20):8027-34. doi: 10.1021/jo0511187.
9
Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands.合成及结构药理学研究:基于环丙烷的 4-甲基组氨酸的刚性类似物作为组氨酸 H3/H4 受体配体。
Bioorg Med Chem. 2010 Feb;18(3):1076-82. doi: 10.1016/j.bmc.2009.12.046. Epub 2009 Dec 23.
10
Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.一系列新型1H-4-取代咪唑基组胺H3受体配体的鉴定及药理学特性研究
J Pharmacol Exp Ther. 1999 May;289(2):1151-9.

本文引用的文献

1
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy.匹莫林在发作性睡病治疗中的概况:设计、研发及治疗地位
Drug Des Devel Ther. 2018 Aug 30;12:2665-2675. doi: 10.2147/DDDT.S101145. eCollection 2018.
2
Progress in the development of histamine H receptor antagonists/inverse agonists: a patent review (2013-2017).组胺H受体拮抗剂/反向激动剂的研发进展:专利综述(2013 - 2017年)
Expert Opin Ther Pat. 2018 Mar;28(3):175-196. doi: 10.1080/13543776.2018.1424135. Epub 2018 Jan 15.
3
From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
从肽到拟肽:基于环丙烷结构特征的策略。
Chemistry. 2017 Oct 17;23(58):14394-14409. doi: 10.1002/chem.201702119. Epub 2017 Aug 22.
4
Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.具有三维结构多样性的高度构象受限环丙烷连接体极大地增强了环肽的细胞渗透性。
Chemistry. 2017 Mar 2;23(13):3034-3041. doi: 10.1002/chem.201604946. Epub 2016 Dec 27.
5
Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.新型组胺 H4 受体配体及其潜在的治疗应用:最新进展。
Expert Opin Ther Pat. 2014 Nov;24(11):1185-97. doi: 10.1517/13543776.2014.959494. Epub 2014 Sep 15.
6
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.具有双环[3.1.0]己烷骨架的构象受限GABA作为首个高选择性BGT-1抑制剂。
ACS Med Chem Lett. 2014 Jun 16;5(8):889-93. doi: 10.1021/ml500134k. eCollection 2014 Aug 14.
7
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.基于环丙烷的 GABA 构象限制:一种立体化学多样性导向的策略:鉴定出一种高效的 GABA 转运体抑制剂先导化合物。
Bioorg Med Chem. 2013 Sep 1;21(17):4938-50. doi: 10.1016/j.bmc.2013.06.063. Epub 2013 Jul 8.
8
Investigation of the noncovalent binding mode of covalent proteasome inhibitors around the transition state by combined use of cyclopropylic strain-based conformational restriction and computational modeling.通过结合使用环丙基应变的构象限制和计算建模,研究共价蛋白酶体抑制剂在过渡态周围的非共价结合模式。
J Med Chem. 2013 Jul 25;56(14):5829-42. doi: 10.1021/jm400542h. Epub 2013 Jul 9.
9
Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strain.基于环丙基张力的三维结构多样性导向的拟肽。
Org Lett. 2013 Apr 5;15(7):1686-9. doi: 10.1021/ol400469w. Epub 2013 Mar 25.
10
Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.基于环丙烷的立体化学多样性导向构象限制策略:具有 2,3-甲烷丁烷骨架的组胺 H3 和/或 H4 受体配体。
Org Biomol Chem. 2012 Jan 28;10(4):736-45. doi: 10.1039/c1ob06496g. Epub 2011 Nov 28.